ACXP: Nilai perusahaan marang bathi resik Acurx Pharmaceuticals, Inc.

Lambang korporat lan logo Acurx Pharmaceuticals Inc. (ACXP)

Acurx Pharmaceuticals (ACXP) aims to expand its portfolio of innovative drugs against resistant infections to capture market share. This chart from GURU.Markets featuring the -0.80 indicator complements the risk data: global conflicts are disrupting logistics and slowing international trials. Consequently, Acurx Pharmaceuticals is spending its existing capital on pre-commercial development in the total absence of operating revenue.

Pangali P/E: Acurx Pharmaceuticals, Inc. (ACXP) kanggo 04.07.2022 - 12.11.2026

Rincian analitis perusahaan Acurx Pharmaceuticals

- rega lan prakiraan konsensus rega:
Rega saham Acurx|ACXP - Target konsensus
- informasi kapitalisasi pasar:
Nilai pasar Acurx Pharmaceuticals, Inc.|ACXP - Nilai Total Perusahaan
- indikator nilai aset resik miturut neraca:
Nilai Akuntansi saben Saham Acurx Pharmaceuticals|ACXP - Kapitalisasi Buku|Kapitalisasi Pasar marang Nilai Buku acurxpharma.com|ACXP - Total Aset Perusahaan
- data liabilitas lan likuiditas perusahaan:
Rasio Total Utang marang Ekuitas Acurx Pharmaceuticals|ACXP - Utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal Acurx|ACXP - Utang perusahaan|Utang-utang marang nilai buku Acurx Pharmaceuticals, Inc.|ACXP - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Acurx Pharmaceuticals|Likuiditas darurat acurxpharma.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
ACXP - Bathi resik perusahaan|Prakiraan bathi perusahaan Acurx Pharmaceuticals|ACXP - Pangali P/E|Pangali Forward P/E Acurx|ACXP - Pangali PEG|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Acurx Pharmaceuticals, Inc.|ACXP - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham (EPS TTM) Acurx Pharmaceuticals|ACXP - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan acurxpharma.com|ACXP - Wutah bathi resik saben saham ing taun iki|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep Acurx Pharmaceuticals
Analisis komprehensif perusahaan:ACXP (acurxpharma.com)
Produk mawa merek Acurx Pharmaceuticals

Fundamental asset selection is based on comparing market quotes with actual business performance. The P/E ratio measures the cost of one unit of net profit, determining the investment payback period. For Acurx Pharmaceuticals (ACXP), this calculation reflects the capitalization of next-generation antibiotic potential coupled with optimized supply chains. The stability of substance supplies directly impacts future earnings. By analyzing the historical P/E chart of Acurx Pharmaceuticals (ACXP), an investor can identify points of asset undervaluation.

Pesaing wigati

Pangali P/E armatapharma.com